Showing results (231-240 of 297) with videos related to
Sort By:
Pageof 30
The Journal of Rheumatology|January 15, 2025
Association Between Patient Perception of Disease Status and Different Components of the Minimal Disease Activity Criteria in Psoriatic ArthritisSarah M Yazji, Philip S Helliwell, Andra Balanescu, et al.The Journal of Rheumatology. Supplement|June 3, 2018
Proceedings of the 2017 GRAPPA Collaborative Research Network MeetingDeepak R Jadon, Vinod Chandran, Carmel Stober, et al.The Journal of Rheumatology|March 15, 2026
Further validation of a questionnaire to assess flare in psoriatic arthritis: determination of cut-off and longitudinal changePhilip S Helliwell, Juan D Cañete, Laura C Coates, et al.Seminars in Arthritis and Rheumatism|May 19, 2023
Living with foot and ankle disorders in rheumatic and musculoskeletal diseases: A systematic review of qualitative studies to inform the work of the OMERACT Foot and Ankle Working GroupLara S Chapman, Caroline A Flurey, Anthony C Redmond, et al.RMD Open|July 16, 2020
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II studyPhilip J Mease, Dafna D Gladman, Atul Deodhar, et al.The Journal of Rheumatology. Supplement|June 2, 2021
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.The Journal of Rheumatology|March 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.Annals of the Rheumatic Diseases|September 30, 2019
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trialPhilip J Mease, Josef S Smolen, Frank Behrens, et al.The Journal of Rheumatology. Supplement|June 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.The Journal of Rheumatology|March 2, 2021
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.Pageof 30